| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.04 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |